155 related articles for article (PubMed ID: 1875566)
1. [Effect of biological response modifiers on a spontaneous murine renal cell carcinoma regression of metastases caused by the streptococcal preparation OK-432].
Tanji S
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):716-25. PubMed ID: 1875566
[TBL] [Abstract][Full Text] [Related]
2. [Combined effect of intraperitoneally administered OK-432 and recombinant interleukin (rIL-2) against mouse tumors].
Fujioka T; Shiraishi M; Tanji S; Koike H; Kumagai K; Kubo T; Ohhori T
Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):948-56. PubMed ID: 2789265
[TBL] [Abstract][Full Text] [Related]
3. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.
Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N
Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors.
Fujioka T; Ishikura K; Tanji S; Okamoto T; Koike H; Aoki H; Ohhori T; Kubo T
Int J Immunopharmacol; 1990; 12(4):419-26. PubMed ID: 2391188
[TBL] [Abstract][Full Text] [Related]
5. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
Ishida N; Saito M; Nanjo M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
[TBL] [Abstract][Full Text] [Related]
6. Role of natural killer activity in development of spontaneous metastases in murine renal cancer.
Salup RR; Herberman RB; Wiltrout RH
J Urol; 1985 Dec; 134(6):1236-41. PubMed ID: 4057425
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines.
Nanjo M; Moriya Y; Hashimoto S; Kataoka M; Saito M; Yoshida T; Ishida N
Int J Immunopharmacol; 1991; 13(2-3):205-15. PubMed ID: 1906439
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
Kaji R; Yoshida H; Yanagawa T; Sato M
J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model.
Hillman GG; Younes E; Visscher D; Ali E; Lam JS; Montecillo E; Pontes JE; Haas GP; Puri RK
Cell Immunol; 1995 Feb; 160(2):257-63. PubMed ID: 7720087
[TBL] [Abstract][Full Text] [Related]
11. Combination of radiation and vaccination with autologous tumor cells expressing IL-2, IFN-gamma and GM-CSF for treatment of murine renal carcinoma.
Maini A; Nishisaka N; Kinoshita Y; Jones RF; Wang CY; Haas GP
In Vivo; 2003; 17(2):119-23. PubMed ID: 12792971
[TBL] [Abstract][Full Text] [Related]
12. Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice.
Moriya Y; Sato H; Ito K; Saito M; Yoshida T; Ishida N
Cancer Immunol Immunother; 1993; 36(4):245-50. PubMed ID: 8094999
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Fujioka T; Hasegawa M; Ishikura K; Nomura K; Okamoto T; Tanji S; Koike H; Kubo T
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2031-6. PubMed ID: 2221926
[TBL] [Abstract][Full Text] [Related]
14. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
Yamaue H; Tanimura H; Iwahashi M; Tsunoda T; Tani M; Inoue M
Biotherapy; 1990; 2(1):51-61. PubMed ID: 2400628
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of interleukin-2 entrapped in liposomes on murine renal cell carcinoma.
Oya M
Keio J Med; 1994 Mar; 43(1):37-44. PubMed ID: 8189679
[TBL] [Abstract][Full Text] [Related]
16. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
[TBL] [Abstract][Full Text] [Related]
17. Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.
Wysocki PJ; Kazimierczak U; Suchorska W; Kotlarski M; Malicki J; Mackiewicz A
Cancer Gene Ther; 2010 Jul; 17(7):465-75. PubMed ID: 20168352
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.
Gregorian SK; Battisto JR
Cancer Immunol Immunother; 1990; 31(6):325-34. PubMed ID: 2386978
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
